Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT
Xilio Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.93M | 1.72M | 2.26M | 2.36M | n/a | 2.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 449K | 460K | 492K | 499K | 489K | 473K | 445K | 440K | 394K | 382K | 373K | 350K |
Gross Profit | 2.93M | 1.72M | 2.26M | 2.36M | n/a | 2.45M | -460K | -492K | -499K | -489K | -473K | -445K | -440K | -394K | -382K | -373K | -350K |
Operating Income | -13.85M | -13.63M | -14.76M | -14.7M | -17.49M | -18.13M | -17.36M | -20.12M | -23.53M | -23.17M | -20.21M | -24.55M | -21.22M | -19.56M | -15.96M | -23.01M | -16.52M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 100K | n/a | 200.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -22.65M | -22.47M | -19.79M | -24.61M | -21.35M | -19.7M | -16.25M | -23.18M | -16.67M |
Net Income | -13.27M | -13.09M | -14.02M | -13.93M | -17.2M | -17.66M | -16.75M | -19.36M | -21.27M | -21.77M | -19.37M | -24.61M | -21.48M | -19.7M | -16.25M | -23.18M | -16.67M |
Selling & General & Admin | 8.52M | 6.52M | 6.31M | 5.82M | 6.14M | 5.95M | 6.31M | 6.9M | 7.39M | 8.17M | 7.17M | 8.31M | 6.3M | 8.2M | 5.49M | 5.26M | 4.9M |
Research & Development | 8.27M | 8.84M | 10.76M | 11.22M | 10.4M | 11.74M | 11.05M | 13.22M | 16.13M | 15M | 13.04M | 16.25M | 14.92M | 11.35M | 10.47M | 17.75M | 11.62M |
Other Expenses | n/a | n/a | -41K | 30K | 948K | n/a | 613K | 761K | 880K | 701K | 416K | -61K | -129K | -145K | -290K | -174K | -147K |
Operating Expenses | 16.78M | 15.35M | 17.02M | 17.06M | 17.49M | 17.68M | 17.36M | 20.12M | 23.53M | 23.17M | 20.21M | 24.55M | 21.22M | 19.56M | 15.96M | 23.01M | 16.52M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 100K | 200K | 200K | n/a | n/a | n/a | n/a | 129K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 5.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.78M | 15.35M | 17.02M | 17.06M | 17.49M | 18.13M | 17.36M | 20.12M | 23.53M | 23.17M | 20.21M | 24.55M | 21.22M | 19.56M | 15.96M | 23.01M | 16.52M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.38M | -701K | -416K | n/a | 129K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 74.7M | 64.68M | 63.47M | 57.76M | 27.91M | 27.56M | 27.52M | 27.47M | 27.43M | 27.42M | 27.4M | 27.38M | 27.37M | 20.06M | 26.67M | 26.67M | 26.67M |
Shares Outstanding (Diluted) | 74.7M | 64.68M | 63.47M | 57.76M | 27.91M | 27.56M | 27.52M | 27.47M | 27.43M | 27.42M | 27.4M | 27.38M | 27.37M | 20.06M | 26.67M | 26.67M | 26.67M |
EPS (Basic) | -0.18 | -0.2 | -0.22 | -0.24 | -0.62 | -0.64 | -0.61 | -0.7 | -0.78 | -0.79 | -0.71 | -0.9 | -0.78 | -0.98 | -0.61 | -0.87 | -0.63 |
EPS (Diluted) | -0.18 | -0.2 | -0.22 | -0.24 | -0.62 | -0.64 | -0.61 | -0.7 | -0.78 | -0.79 | -0.71 | -0.9 | -0.78 | -0.98 | -0.61 | -0.87 | -0.63 |
EBITDA | -13.35M | -13.25M | -14.42M | -14.23M | -16.1M | -17.11M | -16.9M | -19.62M | -23.03M | -22.68M | -19.73M | -24.11M | -20.78M | -19.16M | -15.58M | -22.63M | -16.17M |
EBIT | -13.85M | -13.63M | -14.8M | -14.67M | -16.54M | -17.55M | -17.36M | -20.12M | -23.53M | -23.17M | -20.21M | -24.55M | -21.22M | -19.56M | -15.96M | -23.01M | -16.52M |
Depreciation & Amortization | 497K | 375K | 381K | 445K | 443K | 449K | 460K | 492K | 499K | 489K | 473K | 445K | 440K | 394K | 382K | 373K | 350K |